Synapse - Carly Schwartz

Carly Schwartz

Research Focus

Research and Technology Management; Clinical Research Supervisor

Recent additions – View all

Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights
Meeting Abstract

Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save
A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer
Meeting Abstract

Tuli, R.; Keane, F.; Schoenfeld, J. D.; O'Connor, C.; White, C.; Chou, J. F.; Schwartz, C.; Larsen, M.; Brenner, R.; Park, W.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save
Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
Meeting Abstract

Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Co-authors at MSK

3

Keane
3

O'Connor
3

O'Reilly
3

Park
3

Varghese
2

Brenner
2

Capanu
2

Chou
2

Crane
2

Reyngold
2

Schoenfeld
2

Vardhana
2

Yu
1

Balogun
1

Basturk
1

Digugli...
1

Iacobuz...
1

Joshi
1

Karnoub
1

Kelsen
1

Perry
1

Riaz
1

Singhal
1

Tarcan
1

Umeda
1

White
1

Zervoud...
1

Zhang

Types of Work

Publications

Journal of Clinical Oncology (3)